Meeting
2016 ASCO Annual Meeting
Longitudinal changes in patient-reported symptoms and physical function during taxane-based chemotherapy in breast cancer patients.
Authors
Scott M. Monfort
Department of Mechanical and Aerospace Engineering, The Ohio State University, Columbus, OH
Scott M. Monfort , Xueliang Jeff Pan , Robyn Patrick , Janani Singaravelu , Rachel M. Layman , Ewa Mrozek , Bhuvaneswari Ramaswamy , Raquel E. Reinbolt , Robert Wesolowski , Michelle Joy Naughton , Charles L. Shapiro , Charles L. Loprinzi , Ajit M.W. Chaudhari , Maryam B. Lustberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Survivorship
Citation
J Clin Oncol 34, 2016 (suppl; abstr 10098)
DOI
10.1200/JCO.2016.34.15_suppl.10098
Abstract #
10098
Poster Bd #
86
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
The effect of structured exercise during chemotherapy on chemotherapy-induced peripheral neuropathy (CIPN): A role for interoceptive brain circuitry.
First Author: Ian Kleckner
Poster
2022 ASCO Annual Meeting
Differences in clinician and patient assessment of baseline neuropathy in patients receiving taxane-based chemotherapy enrolled to SWOG S1714 (NCT# 03939481).
First Author: Meghna S. Trivedi
Poster
2015 Breast Cancer Symposium
Predictors of chemotherapy-induced peripheral neuropathy among breast cancer patients treated with taxanes.
First Author: Nellowe Candelario
Poster
2023 ASCO Annual Meeting
Impact of exercise on chemotherapy-induced peripheral neuropathy (CIPN) in survivors with post-treatment primary breast cancer.
First Author: Kirin Saint